CWA Asset Management Group’s Core Laboratories CLB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$1.61M Sell
166,449
-1,588,636
-91% -$18.4M 0.05% 323
2026
Q2
$20.4M Buy
1,755,085
+14,084
+0.8% +$201K 0.62% 30
2026
Q1
$29.2M Buy
1,741,001
+1,118,548
+180% +$20M 0.99% 21
2025
Q4
$10M Buy
+622,453
New +$9.26M 0.36% 56
2023
Q1
– Sell
-129,772
Closed -$2.63M – 328
2022
Q4
$2.63M Buy
+129,772
New +$2.52M 0.21% 98

Other funds holding CLB

CWA Asset Management Group's CLB Position: Q3 2026 in Review

CWA Asset Management Group reduced its Core Laboratories (CLB) stake by 91% in Q3 2026, selling an estimated $18.4M and leaving 166,449 shares worth $1.61M. The position accounts for 0.05% of the portfolio, ranked #323.

CWA Asset Management Group first reported a position in CLB in Q4 2022 and has held it in 5 quarters since. The position peaked at $29.2M in Q1 2026. 180 funds tracked by Wall St. Rank hold CLB as of Q3 2026.

  • CWA Asset Management Group held 166,449 shares of Core Laboratories worth $1.61M as of Q3 2026.
  • CWA Asset Management Group sold 1,588,636 Core Laboratories shares in Q3 2026, an estimated $18.4M.
  • Core Laboratories made up 0.05% of CWA Asset Management Group's portfolio in Q3 2026, its #323 holding.
  • CWA Asset Management Group first reported a position in Core Laboratories in Q4 2022 and has held it in 5 quarters since.
  • CWA Asset Management Group's Core Laboratories position peaked at $29.2M in Q1 2026.
  • 180 funds tracked by Wall St. Rank held Core Laboratories as of Q3 2026.

Based on CWA Asset Management Group's 13F filing for Q3 2026, filed 19 Oct 2026.